Despite longstanding reliance on sputum smear microscopy, culture methods, and chest X-rays, conventional TB diagnostics ...

PEER-led approaches may significantly improve tuberculosis (TB) screening among people who use drugs (PWUD)—a population at ...

On World TB Day in March 2024, the he­­alth ministry announced grim statistics: newly notified cases increased from 11,050 in ...

Patanjali’s study finds ‘Chhoti Kateli’ may help fight tuberculosis and reduce drug resistance, offering hope for safer herbal treatments.

The story of Fimbrion is a footnote in the much larger story of this president’s determination to withdraw the federal ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...

Despite having a large pharmaceutical manufacturing base, Pakistan has only four medicines approved by the World Health ...

Both are capable of affecting the lungs and sharing similar symptoms such as cough and shortness of breath but knowing their ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

MDR-TB is a particularly complicated form of TB, resisting at least two of the standard four-drug, anti-TB drugs. Inadequately treated patients are likely to increase selective pressure ...